Early fatal hemoptysis after first-dose, first-line pembrolizumab in a central lung cancer: did tumor shrinkage matter?

Immunotherapy,Volume 11, Issue 3, Page 161-166, February 2019.

Source: Immunotherapy - January 16, 2019 Category: Allergy & Immunology Authors: Francesco Facchinetti Maria Majori Mariangela Sabato Letizia Gnetti Marcello Tiseo Source Type: research